Display options
Cite
Ghiasvand H, Moradi-Joo M, Abolhassani N, et al. Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive. Med J Islam Repub Iran. 2016;30:330
Ghiasvand, H., Moradi-Joo, M., Abolhassani, N., Ravaghi, H., Raygani, S. M., & Mohabbat-Bahar, S. (2016). Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive. Medical journal of the Islamic Republic of Iran, 30330.
Ghiasvand, Hesam, et al. "Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive." Medical journal of the Islamic Republic of Iran vol. 30 (2016): 330.
Ghiasvand H, Moradi-Joo M, Abolhassani N, Ravaghi H, Raygani SM, Mohabbat-Bahar S. Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive. Med J Islam Repub Iran. 2016 Feb 17;30:330. eCollection 2016. PMID: 27390700; PMCID: PMC4898845.
Copy Download .nbib Format: NLM
Share it on

Med J Islam Repub Iran. 2016 Feb 17;30:330. eCollection 2016.

Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive.

Medical journal of the Islamic Republic of Iran

Hesam Ghiasvand, Mohammad Moradi-Joo, Nazanin Abolhassani, Hamid Ravaghi, Seyed Mansoor Raygani, Sahar Mohabbat-Bahar

Affiliations

  1. PhD of Health Economics, Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. [email protected] .
  2. MSc in Health Technology Assessment, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. [email protected].
  3. PhD of Health Policy and Management, Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. [email protected].
  4. PhD of Health Policy, Assistant Professor, Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran. [email protected].
  5. Physical Medicine and Rehabilitation Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. [email protected] .
  6. PhD student in Psychology, Ferdowsi University of Mashhad, Faculty of Psychology and Educational Sciences, Mashhad, Iran. [email protected] .

PMID: 27390700 PMCID: PMC4898845

Abstract

BACKGROUND: It is estimated that major depression disorders constitute 8.2% of years lived with disability (YLDs) globally. The repetitive Transcranial Magnetic Stimulation (rTMS) and Electroconvulsive Therapy (ECT) are two relative common interventions to treat major depressive disorders, especially for treatment resistant depression. In this study the cost- effectiveness and cost-utility of rTMS were compared with ECT in Iranian population suffering from major depressive disorder using a decision tree model.

METHODS: A decision tree model conducted to compare the cost-effectiveness ratio of rTMS with ECT in a health system prospective and 7 months' time horizon. The outcome variables were: response rate, remission rate and quality-adjusted life-years (QALYs) of the rTMS and ECT as primary and secondary outcomes extracted from systematic reviews and randomized control trials. The costs were also calculated through a field study in one clinic and one hospital; the direct costs have only been considered.

RESULTS: The total cost for rTMS and ECTstrategieswere11015000Rials (373US$) and 11742700 Rials (397.7US$), respectively. Also the rTMS/ECT ratio of costs per improved patients was 1194410Rials (40.5 US$); the ratio for costs per QALYs utility was 21017139 Rials (711.72 US$). The incremental cost- effectiveness ratio of rTMS versus ECT was 1194410 Rials (40.44 US$) after treatment and maintenance courses.

CONCLUSION: Given the current prevalence of depressive disorders in Iranian population, the ECT is more cost-effective than TMS. The sensitivity analysis showed that if the prevalence of major depressive disorders declines to below 5% or the costs of rTMS decrease (rTMS provided by public sector), then the rTMS becomes more cost-effective compared with ECT. However, efficacy of rTMS depends on the frequency of pulsed magnetic field, the location of rTMS on the head, the number of therapeutic sessions and the length of each session.

Keywords: Decision tree; Electroconvulsive Therapy; Major Depressive disorders; repetitive Transcranial Magnetic Stimulation

References

  1. Int J Prev Med. 2010 Spring;1(2):81-91 - PubMed
  2. Adv Ther. 2009 Mar;26(3):346-68 - PubMed
  3. Health Technol Assess. 2007 Jul;11(24):1-54 - PubMed
  4. J ECT. 2011 Dec;27(4):310-4 - PubMed
  5. Popul Health Metr. 2009 Jun 15;7:9 - PubMed
  6. Lancet. 2006 Jan 14;367(9505):153-67 - PubMed
  7. Biol Psychiatry. 2004 Feb 1;55(3):301-12 - PubMed
  8. Psychol Med. 2011 Jun;41(6):1187-96 - PubMed
  9. PLoS Med. 2006 Nov;3(11):e442 - PubMed
  10. Arch Iran Med. 2014 May;17(5):336-42 - PubMed
  11. Depress Anxiety. 2013 Jul;30(7):614-23 - PubMed
  12. CNS Spectr. 2004 Jun;9(6):476-82 - PubMed
  13. Am J Psychiatry. 2007 Jan;164(1):73-81 - PubMed
  14. PLoS Med. 2013 Nov;10(11):e1001547 - PubMed
  15. Psychol Med. 2014 Jan;44(2):225-39 - PubMed
  16. J Affect Disord. 2008 Aug;109(3):273-85 - PubMed
  17. Lancet. 2003 Mar 8;361(9360):799-808 - PubMed

Publication Types